N@N

Market Maker Surveillance Report. BP, MRK, KERX, ORCL, CXMSF, CBIS, Highest Net Buy Volume With Lowest Price Friction For Mond

^{Published on 2012-03-05 18:01:17 - WOPRAI}
 

March 5, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3570 companies with "abnormal" market making, 2317 companies with positive Friction Factors and 3755 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Monday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. BP PLC-SPONS ADR (NYSE:BP), MERCK & CO. , INC. (NYSE:MRK), KERYX BIOPHARMACEUTICALS (NASDAQ:KERX), Oracle Corp (NASDAQ:ORCL), CEMEX SAB-CPO (OTC:CXMSF), CANNABIS SCIENCE INC (OTCBB:CBIS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     BP         $0.760       1.60%        8,111,061       38.57%       5,611,274       26.68%       2,499,787       32,892  
     MRK        $0.520       1.37%        6,390,535       34.26%       4,619,453       24.77%       1,771,082       34,059  
     KERX       $1.250       33.78%       15,377,127      51.87%       14,012,415      47.27%       1,364,712       10,918  
     ORCL       $0.280       0.93%        17,376,092      51.60%       16,247,584      48.25%       1,128,508       40,304  
     CXMSF      $0.040       5.29%        6,000,000       48.00%       1,000,000       8.00%        5,000,000       1,259,446
     CBIS       $0.023       17.72%       16,224,011      52.27%       14,808,050      47.71%       1,415,961       629,316 

For example, the chart above shows BP with a Net Buy Volume of 2,499,787 shares and a Friction Factor of 32,892 shares. That means that it takes 32,892 more shares of buying than selling to move BP higher by one penny. This means the Market Makers are allowing the stock to move up higher as of Monday (lower friction). And with one of the highest Net Buy Volumes, the combination of low friction and high net buy volume is bullish.

BP PLC-SPONS ADR (NYSE:BP) - BP p.l.c. provides fuel for transportation, energy for heat and light, retail services, and petrochemicals products. Its Exploration and Production segment engages in the oil and natural gas exploration, field development, and production; midstream transportation, and storage and processing; and marketing and trading of natural gas, including liquefied natural gas (LNG), and power and natural gas liquids (NGL). This segment has exploration and production activities in Angola, Azerbaijan, Canada, Egypt, Norway, Russia, Trinidad and Tobago, the United Kingdom, and the United States, as well as in Asia, Australasia, South America, North Africa, and the Middle East. This segment also owns and manages crude oil and natural gas pipelines; processing facilities and export terminals; and LNG processing and transportation, as well as NGL extraction facilities. BP p.l.c. has interests in the Trans-Alaska pipeline system, the Forties pipeline system, the Central Area transmission system pipeline, the South Caucasus Pipeline, and Baku-Tbilisi-Ceyhan pipeline, as well as in LNG plants located in Trinidad, Indonesia, and Australia. The companys Refining and Marketing segment involves in the supply and trading, refining, manufacturing, marketing, and transportation of crude oil, petroleum, and petrochemicals products and related services to wholesale and retail customers primarily under the BP, Castrol, ARCO, and Aral brands. Its Other Businesses and Corporate segment produces and markets rolled aluminum products, as well as generates energy through wind, solar, biofuels, hydrogen, and carbon capture and storage sources; and engages in shipping activities. The company was founded in 1889 and is headquartered in London, the United Kingdom.

MERCK & CO. , INC. (NYSE:MRK) - Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The companys Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, diabetes and obesity, infectious diseases, neurosciences and ophthalmology, oncology, vaccines, and women's health and endocrine. This segment also offers human health vaccines, such as preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products. This segment offers antibiotics, anti-inflammatory products, vaccines, products for the treatment of fertility disorders, and parasiticides for cattle, swine, horses, poultry, dogs, cats, salmons, and fish. The Consumer Care segment develops, manufactures, and markets over-the-counter, foot care, and sun care products. Its over-the-counter product line includes non-drowsy antihistamines; treatment for occasional constipation; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and treatment for frequent heartburn. This segments foot care products comprise topical antifungal, and foot and sneaker odor/wetness products; and sun care products include sun care lotions, sprays and dry oils; and sunburn relief products. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, and managed health care providers, as well as food chain and mass merchandiser outlets in the United States and Canada. Merck & Co., Inc. was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

KERYX BIOPHARMACEUTICALS (NASDAQ:KERX) - Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease. The companys products under development include KRX-0401 (perifosine), a phase III clinical stage product, which is an oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects other pathways associated with programmed cell death, cell growth, cell differentiation, and cell survival; and Zerenex (ferric citrate), an oral iron-based compound, which completed phase II clinical stage for the treatment of hyperphosphatemia in patients with end-stage renal disease. It has strategic alliances with AEterna Zentaris Inc.; Panion & BF Biotech, Inc.; Japan Tobacco Inc.; and Torii Pharmaceutical Co., Ltd. for the manufacture and commercialization of its products. Keryx Biopharmaceuticals, Inc. was founded in 1998 and is based in New York, New York.

Oracle Corp (NASDAQ:ORCL) - Oracle Corporation, an enterprise software company, develops, manufactures, markets, distributes, and services database and middleware software, applications software, and hardware systems worldwide. It engages in licensing database and middleware software, including database, application server and application grid, SOA suite and business process management, data migration and integration, business intelligence, identity and access management, content management, portal and user interaction, developer tools, Oracle enterprise manager, and Java platform. The company also offers application software, including enterprise resource planning, customer relationship management, enterprise performance management, supply chain management, business intelligence applications, enterprise project portfolio management, and industry-specific applications; and software license updates and product support services. In addition, it provides hardware systems products, such as servers, storage products, Solaris operating system and other hardware-related software, and networking components and products; and hardware systems support services. Further, the company offers consulting services, which include enterprise architecture design and implementation, business/IT strategy alignment, business process simplification, solution integration, and product implementation, enhancements, and upgrades; on demand and advanced customer services; and training services, as well as certification programs. It markets and sells its products directly, as well as through resellers, system integrators/implementers, consultants, education providers, Internet service providers, network integrators, and independent software vendors to various industries, government agencies, and educational institutions. The company has a strategic alliance with Cap Gemini S.A. to market and implement Oracle Revenue Management for public. Oracle was founded in 1977 and is headquartered in Redwood City, California.

CEMEX SAB-CPO (OTC:CXMSF) - CEMEX, S.A.B. de C.V., through its subsidiaries, engages in the production, marketing, distribution, and sale of cement, ready-mix concrete, aggregates, and other construction materials. It sells its products primarily to distributors in the construction industry. The company has operations in North America, Europe, South America, Central America, the Caribbean, Africa, the Middle East, and Asia. CEMEX, S.A.B. de C.V. was founded in 1906 and is based in Garza Garcia, Mexico.

CANNABIS SCIENCE INC (OTCBB:CBIS) - Cannabis Science, Inc. engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing blood pressure and cancer medications, as well as HIV and bird flu medications. Cannabis Science, Inc. is based in Colorado Springs, Colorado.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net